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Antonio Pelliccia, MD,* Norimitsu Kinoshita, MD,† Cataldo Pisicchio, MD,* Filippo Quattrini, MD,*
Fernando M. DiPaolo, MD,* Roberto Ciardo, MD,* Barbara Di Giacinto, MD,*
Emanuele Guerra, MD,* Elvira De Blasiis, MD,* Maurizio Casasco, MD,* Franco Culasso, PHD,‡
Barry J. Maron, MD§
Rome, Italy; Yokohama, Japan; and Minneapolis, Minnesota
Objectives The aim of this study was to assess incidence of cardiac events and/or left ventricular (LV) dysfunction in ath-
letes exposed to strenuous and uninterrupted training for extended periods of time.
Background Whether highly intensive and uninterrupted athletic conditioning over a long period of time might be responsible
for cardiac events and/or LV dysfunction is unresolved.
Methods We assessed clinical profile and cardiac dimensions and function in 114 Olympic athletes (78% male; mean age
22  4 years), free of cardiovascular disease, participating in endurance disciplines, who experienced particu-
larly intensive and uninterrupted training for 2 to 5 consecutive Olympic Games (total, 344 Olympic events), over
a 4- to 17-year-period (mean 8.6  3 years).
Results Over the extended period of training and competition, no cardiac events or new diagnoses of cardiomyopathies
occurred in the 114 Olympic athletes. Global LV systolic function was unchanged (ejection fraction: 62  5% to
63  5%; p  NS), and wall motion abnormalities were absent. In addition, LV volumes (142  26 ml to 144 
25 ml; p  0.52) and LV mass index (109  21 g/m2 to 110  22 g/m2; p  0.74) were unchanged, and LV
filling patterns remained within normal limits, although left atrial dimension showed a mild increase (37.8  3.7
mm to 38.9  3.2 mm; p  0.001).
Conclusions In young Olympic athletes, extreme and uninterrupted endurance training over long periods of time (up to 17
years) was not associated with deterioration in LV function, significant changes in LV morphology, or occurrence
of cardiovascular symptoms or events. (J Am Coll Cardiol 2010;55:1619–25) © 2010 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.10.068d
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the long-term clinical consequences of cardiac remodeling in
rained athletes and whether chronic exposure to highly inten-
ive athletic conditioning might ultimately be responsible for
bnormal cardiac function and/or adverse events are not
ompletely resolved. Occurrence of “cardiac fatigue” with acute
nd transient left ventricular (LV) systolic dysfunction and
egmental wall motion abnormalities have been reported as an
ffect of prolonged endurance events lasting 3 to 17 h—such as
ron-man triathlon races (1–4)—suggesting that athletic train-
ng, when particularly strenuous, might be responsible for
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okohama, Japan; ‡Department of Experimental Medicine, University La Sapienza,
ome, Italy; and §The Hypertrophic Cardiomyopathy Center, Minneapolis Heart
nstitute Foundation, Minneapolis, Minnesota.t
Manuscript received January 13, 2009; revised manuscript received October 27,
009, accepted October 27, 2009.eterioration in LV function. We have previously shown
ersistent LV cavity enlargement after prolonged decon-
itioning in former elite athletes (5), and other investi-
ators have reported LV dysfunction in professional
icyclists of middle-age (6). Indeed, more than 10% of
lite cyclists participating in serial Tour de France races
nexpectedly showed systolic dysfunction with marked
See page 1626
V cavity dilation, suggesting a possible diagnosis of
ilated cardiomyopathy (7). More recently, ominous
entricular tachyarrhythmias of right ventricular origin—
ssociated with mild reduction in systolic function— have
een reported in highly trained cyclists (8), suggesting
hat excessive physical training might have adverse elec-
rophysiologic consequences.
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Clinical Consequences of Intense Athletic Training April 13, 2010:1619–25To address this important
clinical issue, we have taken the
opportunity to assess a unique
population of Olympic athletes,
who had been exposed to stren-
uous and uninterrupted training
for extended periods of time,
including participation in up to
5 consecutive Olympic Games.
ethods
tudy population. The Institute of Sports Medicine and
cience in Rome is a medical division of the Italian National
lympic Committee, responsible for the physiologic and
edical evaluation of elite athletes who are members of the
ational teams, from which the participants in the Olympic
ames are selected every 4 years. The medical program for
lympic athletes routinely includes cardiovascular evalua-
ion with history, physical examination, 12-lead and exercise
lectrocardiography (ECG), and 2-dimensional and Dopp-
er echocardiography (9).
For the purpose of this investigation, we selected elite
thletes engaged in those endurance sports known to be
ssociated with the most substantial cardiac remodeling
10,11), who had been training uninterruptedly at the
ighest competitive level in at least 2 consecutive Summer
r Winter Olympic Games from 1992 or 1994, respectively,
nd in the World Championships in the alternate years.
Of the 9,630 athletes evaluated from 1992 to 2008 in our
nstitute, 2,330 were examined within the Olympic pro-
ram; from this population, 460 Italian athletes participat-
ng in particularly intense endurance sports disciplines (i.e.,
ycling, long-distance running, cross-country skiing, swim-
ing, rowing/canoeing, triathlon) were considered for in-
lusion in the study. Among these 460 athletes, 114 had
articipated in 2 or more consecutive Olympic Games and
ad technically satisfactory echocardiograms and therefore
ere selected for the final study population.
These 114 Italian athletes (89 male and 25 female), age
2  4 years at the study entry and with mean body surface
rea (BSA) of 1.9  0.2 m2, were engaged in rowing/
anoeing (n  55), cycling (n  19), middle-distance
unning (800 m; 3,000 m steeple-chase; and 5,000 m; n 
), long-distance running (10,000 m and marathon; n  9),
ross-country skiing (n  15), swimming (400 to 1,500 m;
 6), and triathlon (n  2). Before their initial Olympic
eam selection, the 114 athletes had been involved in regular
ndurance training and competition at the national level for
period of 1 to 15 years (mean 6.9  3.8 years) and, after
lympic selection, trained uninterruptedly for an additional
to 17 years (mean 8.6  3.7 years), for a total training
eriod of 15.5  4.1 years. Training schedules in the
re-Olympic phase usually included 2 daily sessions, each of
2-h duration, including specific work (e.g., on boat for
Abbreviations
and Acronyms
E/A ratio  early-to-late
diastolic peak flow velocity
ratio
ECG  electrocardiography
LV  left ventricularowers/canoeists, on track for runners) and technical aspects Rnd/or general muscle conditioning programs (see detailed
raining schedule in Online Appendix).
The period of observation extended from the time each
thlete underwent our evaluation before first participation in
he Olympic Games to the time the athlete participated in
he most recent Olympics (or World Championships). The
verage time duration between these 2 examinations was 8.6
.7 years (range 4 to 17 years).
Each subject included in this analysis was judged to be
ree of structural cardiovascular disease at initial evaluation
n the basis of medical history, physical examination (with
lood pressure consistently 140/90 mm Hg), exercise
CG testing, and 2-dimensional and Doppler echocardi-
graphy. In athletes with LV wall thickness exceeding
ormal limits (13 mm) and/or markedly dilated LV cavity
60 mm), physiologic remodeling of the athlete’s heart
as distinguished from hypertrophic cardiomyopathy and
ilated cardiomyopathy, respectively, according to previ-
usly described criteria (11–14). Six athletes presented
arkedly abnormal repolarization patterns on ECG, with
nverted T waves of2 mm in2 precordial/standard leads
n the absence of structural cardiac disease (15).
omparison group. To exclude the possibility that
hanges in cardiac function could have precluded athletes
ot included in our study group from continued participa-
ion in consecutive Olympic Games; we assembled a com-
arison group of elite athletes engaged in endurance sports
n the basis of these criteria: 1) participation in only 1
lympic Games; and 2) subsequent 4-year period during
hich systematic training continued but the athletes failed
o be selected as members of Italian teams for the subse-
uent Olympic Games.
From our database of athletes engaged in endurance
ports, who were examined within our Olympic program
rom 1992 to 2000, we identified 97 who met these criteria.
hese athletes were comparable to the study group of the
14 with regard to age (23.5  4.1 years vs. 22.1  3.8
ears) and type of sport participated in (73% vs. 78%
ngaged in rowing/canoeing, cycling, and long-distance
unning).
chocardiography. Two-dimensional and Doppler echo-
ardiographic studies were performed with commercially
vailable Philips Sonos 1500 or Sonos 5500 (Philips Med-
cal System, Bothell, Washington) instruments. Images of
he heart were obtained in multiple cross-sectional planes by
sing standard transducer positions. M-mode echocardio-
rams were derived from 2-dimensional images under direct
natomic visualization and were recorded at 100 mm/s.
easurements of end-diastolic and end-systolic LV cavity
imensions and anterior ventricular septal and posterior free
all thicknesses were obtained in accordance with recom-
endations of the American Society of Echocardiography
16,17). The LV mass was calculated with the formula
roposed by Devereux et al. (18) and was indexed to BSA.
elative wall thickness was the ratio of the average ventric-
u
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April 13, 2010:1619–25 Clinical Consequences of Intense Athletic Traininglar septal and posterior free wall thickness to the radius of
he ventricular cavity.
Ejection fraction was assessed from end-diastolic and
systolic LV volumes, in the apical 4-chamber view and
uantified according to modified Simpson rule (19). In
ddition, the blood pressure/end-systolic volume index ratio
as used to characterize LV systolic function (20). Param-
ters of LV filling were obtained with pulsed Doppler
chocardiography, as previously described (21).
This study was funded by the Italian National Olympic
ommittee and the design was approved by the institutional
eview board. Written informed consent was waived for all
thletes undergoing a standard clinical evaluation pursuant
o Italian law and institute policy. All the records and
linical data on these athletes are kept in a database
aintained by the Institute.
tatistical analysis. Data were expressed as mean  SD.
ifferences between means were assessed with paired or
npaired Student t test, as appropriate. Differences between
roportions were assessed with chi-square test. A 2-tailed
value 0.05 was considered evidence of statistical signif-
cance. Statistical analyses were carried out with the BMDP
tatistical software (22).
esults
thlete’s career. Of the 114 athletes included in this inves-
igation, 42 had participated in 2 consecutive Olympic Games,
0 athletes in 3 Olympics, 20 athletes in 4 Olympics, and 12
thletes in 5 Games. Overall, the athletes in this study
articipated in 344 Olympic Games and 862 World Champi-
nships, and 42 (37%) had been medalists 1 or more times.
ardiac functional changes. Echocardiographic-derived
ndexes of LV function are reported in Table 1. Global systolic
unction did not change over time (ejection fraction: 62 5%
o 63  5%; p  0.09), and no athlete showed decreased LV
ystolic function (i.e., ejection fraction 50%) or regional wall
otion abnormalities at most recent evaluation. The blood
ressure/systolic volume index ratio was within normal limits
n each athlete and did not change over the period of
bservation (4.09  0.9 to 4.31  1.1; p  0.32).
Doppler-derived late diastolic (atrial) peak A-wave velocity
ncreased during the follow-up (32.3  10.0 cm/s to 42.3 
.4 cm/s; 31%; p  0.001), and early diastolic peak
-wave velocity did not change. Therefore, the E/A ratio
ecreased (2.5  0.7 to 1.8  0.4; 28%; p  0.001).
owever, at the most recent evaluation each athlete showed
normal filling pattern (with E/A 1). Deceleration time
ncreased during the observation period from 165  33 to
93  39 (p  0.05).
ardiac dimensional changes. Cardiac dimensions in
lympic athletes at initial and most recent evaluation are
eported in Table 2. No significant changes (by paired t test)
ere observed for LV cavity dimensions, wall thickness,
elative wall thickness, or mass index over the long-term period
f training and competition (Fig. 1). A modest but statistically In
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Clinical Consequences of Intense Athletic Training April 13, 2010:1619–25ignificant dimensional increase was found for left atrial di-
ensions in both men (38.6  3.5 mm to 39.6  2.9 mm;
3%; p  0.01) and women (34.7  2.6 mm to 36.6  3.0
m; 5%; p  0.007). Mild increase of the aortic root
imension was observed in men (33.3  2.1 mm to 34.0 
.7 mm; 2%; p  0.01) but not in women (p  0.70).
linical findings. In the overall population of Olympic
thletes, no cardiovascular symptoms or events occurred
uring the extended period of training and competition, and
ach performed exercise testing to 85% of predicted
aximum heart rate without symptoms at the most recent
valuation. None of the athletes with abnormal repolariza-
ion patterns showed either clinical or morphologic evidence
f cardiac disease.
However, 5 athletes had abnormal clinical findings,
pecified here. Two of these athletes had ventricular tachy-
rrhythmias observed at initial evaluation, including fre-
uent premature ventricular beats with left bundle branch
lock pattern, 1 couplet, and 1 burst of nonsustained
entricular tachycardia (4 beats with R-R interval of 250
s) observed on exercise testing in 1; and rare premature
entricular beats, rare couplets, and 1 short run of nonsus-
ained ventricular tachycardia (3 beats with R-R interval
50 ms) recorded on 24-h ambulatory (Holter) ECG in the
ther. Echocardiography and cardiovascular magnetic reso-
ance were negative for structural or functional cardiac
bnormalities. The first, a 33-year-old male rower, who
articipated in 3 consecutive Olympic Games, remained
symptomatic and without recurrence of arrhythmias after
uccessful radiofrequency ablation. The latter, a 32-year-old
ale cross-country skier, who participated in 2 consecutive
lympic Games, showed disappearance of the ventricular
rrhythmias over the follow-up while undergoing periodical
valuations in our institute.
Three other athletes, including a 35-year-old male mar-
thon runner, a 28-year-old male rower, and a 32-year-old
emale skier, showed T-wave inversion and 2-mm ST-
egment depression on routine exercise ECG, at workloads
f 300 watts, in the absence of cardiac symptoms. Pres-
nce of anomalous origin or course of coronary arteries and
therosclerotic coronary artery disease were excluded by
omputed tomography scan and/or coronary angiography
nd morphologic cardiac abnormalities by echocardiography
nd/or cardiovascular magnetic resonance. These 3 athletes
ere eventually cleared for competition and have remained
symptomatic over the follow-up period encompassing 2
lympic Games.
omparison group. Demographic and cardiac dimen-
ional and functional characteristics of the 97 athletes
omprising the comparison group, who participated in 1
lympic Games, trained over the subsequent 4 years, but
ventually were not selected for the next Olympic Games,
re reported in Table 3. None of these athletes reported
ardiac symptoms or incurred clinical events. No changes
ere evident in cardiac dimensions, including LV volumeand LV mass index, LV systolic function (ejection fraction:Ca T
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April 13, 2010:1619–25 Clinical Consequences of Intense Athletic Training3  6% to 64  6%; p  0.39), blood pressure/systolic
olume index ratio, or LV filling pattern as assessed by
ransmitral Doppler echocardiography.
iscussion
he long-term clinical consequences of cardiac remodeling
n athletes have periodically been questioned and remain
argely unresolved. Most studies describing cardiac remod-
Figure 1 Serial Echocardiographic Views of the LV in an Elite It
Serial echocardiograms obtained from an elite male marathon runner, at the time
at the most recent evaluation before participation in the 2008 Olympic Games (C,
ing; transverse left ventricular (LV) cavity diameter is 60 mm in end-diastole and 3
transverse LV cavity diameter remains 60 mm in end-diastole and 35 mm in end-s
Demographic, Dimensional, and Cardiac FunctionCo prising the Comparison Group Who Parti ipatTable 3 D m graphic, Dimensional, and CardComprising the Comparison Group W
Initial Evaluation
Age (yrs) 23.1 4.2 (15–34)
BSA (m2) 1.86 0.20 (1.48–2.26)
AVS (mm) 9.9 1.2 (7–13)
PFW (mm) 9.7 1.1 (7–12)
LVDd (mm) 53.9 4.4 (45–64)
LV volume (ml) 142.1 26.3 (92–208)
LVM index (g/m2) 108.8 20.6 (57.4–157.1
LA (mm) 36.1 4.0 (25–38)
EF (%) 63.4 5.8 (50–77)
E wave (mm/s) 79.7 16.4 (46–131)
A wave (mm/s) 39.9 8.8 (24–82)
E/A ratio 2.1 0.6 (1.1–3.6)
SBP/ESV 4.4 1.0 (1.9–7.6)
Values are reported as mean  SD (range).
A wave  peak late (atrial) diastolic filling velocity; AVS  anterior
filling velocity; EF  ejection fraction; LA  left atrium; LV  left ve
ventricular mass normalized to body surface area; PFW posterior free wall;
volume.ling in elite athletes have been cross-sectional in design and
nderpowered to clarify the clinical implications and long-
erm consequences of the “athlete’s heart” (10,11,23–28). In
he present study we have addressed this question, by
ssessing a unique population of highly trained, particularly
lite, and largely world-class athletes, who had been en-
aged in endurance training and competition at the highest
evel uninterruptedly for more than 8 years on average,
Marathon Runner
ction for participation in the 1996 Olympic Games (A, B) at age 24 years and
age 36 years. (A) Two-dimensional parasternal long-axis view; (B) M-mode trac-
in end-systole. (C) Parasternal long-axis view; (D) M-mode tracing of the LV;
. PW  posterior wall; VS  ventricular septum.
aracteristics of the 97 AthletesOnly 1 Olympic Gamesnctional Characteristics of the 97 Athletes
rticipated in Only 1 Olympic Games
Most Recent Evaluation p Value
27.1 4.4 (19–38) 0.001
1.86 0.21 (1.48–2.27) 0.84
9.9 1.2 (7–13) 1.0
9.7 1.2 (7–13) 0.94
54.3 4.1 (46–65) 0.47
144.6 25.2 (97–216) 0.51
109.9 22.4 (60.6–166.9) 0.73
36.8 3.7 (29–48) 0.18
64.2 6.0 (51–81) 0.39
80.3 15.7 (47–127) 0.79
42.2 8.5 (23–66) 0.08
1.9 0.5 (1.0–3.3) 0.12
4.7 1.3 (2.5–8.6) 0.21
lar septum; BSA  body surface area; E wave  peak early diastolic
r; LVDd  left ventricular end-diastolic diameter; LVM index  leftalian
of sele
D) at
6 mm
ystoleal Ched ini c Fu
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)
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ntriculaSBP/ESV ratio of systolic blood pressure to normalized end-systolic
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Clinical Consequences of Intense Athletic Training April 13, 2010:1619–25ncluding participation in up to 5 consecutive Olympic
ames. We regarded this unique athletic population, com-
rising top competitors in endurance disciplines (known to
e associated with the most marked cardiac remodeling)
10,11), as an appropriate model to assess the possibility of
dverse cardiovascular consequences of a particularly inten-
ive and chronic exercise training.
The most important finding of our study was the dem-
nstration that, despite exposure to the most vigorous
raining schedule required to compete at the highest (i.e.,
lympic) level, prolonged for an substantial period of time,
o cardiovascular events occurred; nor was deterioration in
lobal LV systolic function or wall motion abnormalities
vident in these athletes. Furthermore, we did not observe
hanges in LV systolic function or incidence of cardiovas-
ular abnormalities in our comparison group of athletes who
ompeted in 1 Olympic Games but failed to qualify for the
ubsequent Games 4 years later.
Therefore, contrary to a previous investigation showing
V dysfunction in professional cyclists participating in Tour
e France races (7), our data show that strenuous and
hronic exercise training is not responsible, per se, for
eterioration of LV systolic function in healthy athletes.
urthermore, we believe that the systematic anti-doping
olicy implemented in recent years had a major impact in
reventing potential harmful effects of doping, including
ossible LV dysfunction. Definitely, the Italian Olympic
thletes included in this study had been cleared at serial
oping controls in the periods preceding and during the
lympic Games. Finally, despite certain morphologic sim-
larities of cardiac remodeling between our chronically
rained athletes and patients with dilated cardiomyopathies,
one of our athletes with marked LV cavity enlargement
xperienced cardiac symptoms or impaired physical perfor-
ance over the long-term observation period of up to 17
ears (15).
As an incidental finding, we observed a modest (although
tatistically significant) increase in left atrial dimension in
ur athletes. This finding was not entirely unexpected,
ecause we have previously reported enlargement of the left
trium as an effect of long-term, intensive training in
ompetitive athletes (28). Such atrial remodeling as well as
V cavity enlargement likely represents a physiologic adap-
ation to increased preload associated with chronic exercise
nd ultimately a mechanism by which LV filling is normal
n trained athletes. Indeed, the physiologic nature of the
trial enlargement is underscored by the preserved systolic
mptying (shown by normal Doppler-flow pattern) and the
bsence of atrial arrhythmias. However, given the youthful
ge of our athletes at most recent assessment, we cannot
xclude the possibility that enlargement of the left atrium
ight be of clinical relevance over the long-term period and
hen athletes achieve more advanced age.
We wish to underscore that the population of elite
thletes who comprise the present investigation is unique by
irtue of their particularly prolonged and successful com-itment to an intensive training schedule over many years.
ecause of the very select nature of this subset of athletes,
owever, results derived from the present investigation
ight not be directly comparable to the natural course of
ardiac functional changes in all competitive athletes under-
oing chronic and intensive conditioning.
In conclusion, this study of uniquely trained Olympic
thletes shows that intensive conditioning over many years
as not associated with inappropriate LV remodeling or
ysfunction or with adverse clinical events, onset of symp-
oms, or new diagnosis of cardiomyopathies. Our findings
upport the benign nature of physiologic heart remodeling
n trained athletes and the safety of long-term and intense
ports participation, even at the highest competitive level.
eprint requests and correspondence: Dr. Antonio Pelliccia,
nstitute of Sports Medicine and Science, Largo Piero Gabrielli 1,
0197 Rome, Italy. E-mail: antonio.pelliccia@coni.it.
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